Immunosenescence and inflammaging are now regarded as central biological mechanisms of ageing. The age-related altered immune system is both weakened and chronically activated – with consequences for susceptibility to infection, tumor development and the large group of inflammation-driven cardiometabolic diseases. In the following, central molecular mechanisms, clinical manifestations and potential intervention approaches are summarized based on current reviews and primary studies on immunosenescence, chronic inflammation and age-associated diseases.
Autoren
- Tanja Schliebe
Publikation
- Longevity-Special
You May Also Like
- Lavender aromatherapy
Take away the fear of the dentist
- Digital dermatology: innovative project examples
AI and eHealth tools in HS care
- Mantle cell lymphoma
Recurrence after BTK inhibition – prognostic factors and treatment options
- Dementia risk with type 2 diabetes
SGLT2 inhibitors with advantages vs. DPP4 inhibitors
- T helper 1 cells
Differentiation and activation of Th1 cells – a multi-omics approach
- Cannabis for schizophrenia
CBD pre-treatment could exacerbate side effects
- Type 2 diabetes: cardiovascular risk reduction is realistic
Modern active ingredients and lifestyle – every step counts
- Case study